Document Detail


Luteal contraception.
MedLine Citation:
PMID:  3281964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Progesterone is an important and unique reproductive hormone. It is the main product of the corpus luteum, dominant in the luteal phase of the cycle, and in pregnancy its secretion continues and increases ensuring maintenance of the early conceptus. At any time in these events, the suspension of progesterone action may interfere with successful reproduction. The term 'luteal contraception' was deliberately chosen for the antifertility effect achieved by the elimination of progesterone action through the use of antiprogesterones in the post-ovulatory phase of the cycle, including early pregnancy. Published clinical experience with RU 486 (Mifepristone) as a post-coital contraceptive, implantation inhibitor, once-a-month pill, menstruation regulator and early abortifacient is reviewed. The potentials and limitations of these uses are discussed and the state of art of 'contragestion' by antiprogestagen treatment summarized.
Authors:
L Kovács
Related Documents :
21503724 - Evaluation of fetal tissue viscoelastic characteristics for robotic fetal surgery.
14609264 - The use of epostane in an attempt to reproduce cystic endometrial hyperplasia in the bi...
648814 - Altered lower esophageal sphincter function during early pregnancy.
21449834 - The association between stillbirth and fetal gender.
23298894 - Prospective, randomized comparison between pulsatile gnrh therapy and combined gonadotr...
8641124 - Is macrosomia associated with poor glycaemic control in diabetic pregnancy?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  3     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1988 Feb 
Date Detail:
Created Date:  1988-05-26     Completed Date:  1988-05-26     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  169-71     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, University Medical School of Szeged, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contraceptives, Oral, Synthetic*
Contraceptives, Postcoital
Estrenes / pharmacology*
Female
Humans
Luteal Phase
Mifepristone
Progesterone / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Contraceptives, Oral, Synthetic; 0/Contraceptives, Postcoital; 0/Estrenes; 57-83-0/Progesterone; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The defective luteal phase.
Next Document:  Experience with diagnosis and treatment of sterility due to abnormality of the infundibulum of the F...